Active Pharmaceutical Ingredients & Raw Materials

Wholesale Active Pharmaceutical Ingredients & Raw Materials

What Are Active Pharmaceutical Ingredients & Raw Materials?

Active Pharmaceutical Ingredients (APIs) are the core therapeutic components in drug formulations, while raw materials include intermediates, excipients, solvents, and bioactive compounds essential for pharmaceutical production. Pharmint curates a global supply of GMP-compliant APIs and raw inputs, tailored for pharmaceutical, nutraceutical, and research applications.

Who Should Use This Category to Source APIs in Bulk?

Pharmint supports:

• Pharma wholesalers supplying regulated and semi-regulated markets
• CDMOs & generics producers scaling production in Africa, LATAM, and Asia
• Government & NGO tenders seeking qualified bulk sources
• Local distribution networks needing stable API and excipient pipelines
• R&D labs and pilot plants sourcing small lots or technical-grade APIs

Why Do Buyers in Africa, LATAM, and Asia Trust Pharmint?

Our platform bridges sourcing gaps by offering:

• Region-aligned documentation: USDMF, EU-CTD, WHO GMP, COA/MSDS
• Access to vetted manufacturers from India, China, EU, and LATAM
• Scalable bulk procurement with flexible MOQs and packaging
• Multilingual support and RFQ workflows optimized for buyers across geographies
• Price transparency and supplier comparisons to support competitive procurement

What Types of APIs and Raw Materials Are Available

Category	Description
APIs & HPAPIs	Oncology, CNS, anti-infectives, metabolic disorders
Intermediates	In-stock and made-to-order building blocks
Excipients	Binders, diluents, preservatives for FDF support
Solvents & Additives	For purification, crystallization, and reaction support
Natural Actives	Nutraceutical compounds and botanical extracts

How Does Pharmint Support Bulk Procurement and Regulatory Compliance?

• Support for local compliance: NAFDAC, INVIMA, COFEPRIS, ASEAN guidelines
• Shipping and documentation expertise for port clearances and customs codes
• Enablement of long-term contracts and repeat supply scheduling
• Disclaimer: For laboratory and formulation use only. Not for direct human/veterinary administration.

How Can Pharmint Simplify API Sourcing for Emerging Market Buyers?

• Multi-vendor sourcing in one dashboard
• Document-traceable listings (CAS, COA, shelf life, GMP status)
• Supplier audits & compliance history available on request
• Batch reservations, production schedules, and sample validation workflows

Sourcing APIs and Raw Materials FAQs

What documents are required to import APIs into Africa or LATAM?

Buyers must obtain COA, MSDS, GMP certificate, and often an End Use Declaration to import APIs into Africa or LATAM, aligning with NAFDAC, ANVISA, or COFEPRIS regulations for customs clearance and local distribution approval.

Can I request GMP, DMF, or CEP files before placing a bulk order?

Yes, Pharmint facilitates access to GMP certificates, DMF summaries, and CEPs from pre-qualified suppliers, ensuring that regulatory review and audit-readiness are part of early-stage procurement planning.

How do I validate the authenticity of a raw material supplier?

Supplier authenticity can be validated through Pharmint’s audit reports, manufacturing site certifications, and document cross-checks, ensuring that each vendor meets compliance, traceability, and licensing standards.

What packaging formats are available for wholesale API shipments?

Pharmint offers bulk APIs in HDPE drums, fiberboard containers, or aluminum foil bags with inner PE liners, based on API sensitivity, ICH storage guidelines, and destination market logistics needs.

Can I source both regulated and unregulated APIs through Pharmint?

Pharmint allows sourcing of APIs for regulated markets (USFDA, EMA) and unregulated use with documentation like COA, MSDS, and GMP to suit both commercial licensing and non-clinical R&D requirements.

Are there APIs available with regional registrations like NAFDAC or INVIMA?

Yes, selected APIs are available with regional approvals or submissions for NAFDAC, INVIMA, and COFEPRIS, easing entry into African and LATAM markets via local dossier support and regulatory alignment.